FEMASYS INC (FEMY) Insider Trading

FEMASYS INC (FEMY) has 10 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $134K. Most recent filing: Aug. 11, 2026.

Filings
10
Purchases
5
$134K
Sales
0
$0
Insiders
9

Most active FEMY insiders

Elefant Dov
Chief Financial Officer
1 bought · 0 sold · Aug. 11, 2026
$50K
Lee-Sepsick Kathy
Chief Executive Officer
1 bought · 0 sold · Aug. 11, 2026
$50K
Canning John Charles
Chief Operating Officer
1 bought · 0 sold · Aug. 11, 2026
$14K
Mifek Jeffrey Gerald
Chief Clinical-Medical Affairs
1 bought · 0 sold · Aug. 11, 2026
$10K
Sipos Jeremy Alexander
Chief Technology Officer
1 bought · 0 sold · Aug. 11, 2026
$10K
Larsen Charles
Director
0 bought · 0 sold · Aug. 11, 2026
$0
Eichenbaum Kenneth D.
Director
0 bought · 0 sold · Aug. 11, 2026
$0
Milnes Alistair
Director
0 bought · 0 sold · Aug. 11, 2026
$0

Latest FEMY Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Aug. 11, 2026 filed June 24, 2026 Eichenbaum Kenneth D. Director $0 880 0% No
Aug. 11, 2026 filed June 24, 2026 Uzialko Edward R Director $0 880 0% No
Aug. 11, 2026 filed June 24, 2026 Milnes Alistair Director $0 880 0% No
Aug. 11, 2026 filed June 24, 2026 Larsen Charles Director $0 880 0% No
Aug. 11, 2026 filed Aug. 7, 2026 Mifek Jeffrey Gerald Chief Clinical-Medical Affairs +$10,000 9,375 New No

Showing the 5 most recent of 10 filings in the last 90 days.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when FEMY insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free